Therefore, as a key regulator of several cellular processes including cell survival, cell growth, cell proliferation and glucose homeostasis and being hyperactivated in more than 50% human tumors where it promotes tumor growth and progression, AKT represents an attractive therapeutic target [5]. The gene discussed is AKT1; the disease is neoplasm.